Multiple C-level insiders are buying - here are three stocks worth
tracking. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏



 

[Morning Watchlist]

_You are receiving this email because you are subscribed to BEHIND THE
MARKETS. If you no longer wish to receive these emails,
please unsubscribe
[[link removed]] here._

_Prefer to view this content on our website? Click here.
[[link removed]]
_

-------------------------

3 STOCKS SEEING FRESH INSIDER BUYING

When corporate insiders buy shares of their own company in the open
market—especially when it happens in clusters and involves C-level
executives—investors should pay attention.

Insiders have a front-row view of operational trends, pipeline health,
competitive dynamics, and capital allocation. They cannot trade on
material nonpublic information, and insider purchases are not a
guarantee of future gains. But decades of research suggests that, in
aggregate, INSIDER PURCHASES TEND TO BE MORE INFORMATIVE THAN INSIDER
SALES, and the signal can be especially meaningful in smaller
companies where information is less efficiently priced.

The most compelling setups tend to share three features:

*
MULTIPLE INSIDERS BUYING WITHIN A SHORT WINDOW (“cluster buying”),
which can indicate shared conviction rather than a one-off decision.
GuruFocus defines “insider cluster buys” as stocks where multiple
officers/directors have bought.

*
SENIOR PARTICIPATION (CEO/CFO/COO or equivalent), because these
insiders typically have the broadest view of the business.

*
OPEN-MARKET PURCHASES (not option exercises), because buying with
fresh capital often reflects a clearer valuation call.

With that framework in mind, below are three stocks that recently saw
insider buying from C-level executives, along with what we’d focus
on as investors.

-------------------------

COMPANY: ACCELERANT HOLDINGS (SYM: ARX)

RECENT PRICE: about $15.84
INSIDER ACTION: 6 insiders bought ~$1.8M in shares
WHAT THE COMPANY DOES: Accelerant operates a data-driven risk exchange
that connects selected specialty insurance underwriters with risk
capital partners, supported by technology, data ingestion, and agency
operations.

WHY INSIDER BUYING MATTERS HERE

Specialty insurance is a scale-and-data game. The winners tend to be
the platforms that can (a) source differentiated risks, (b) price them
accurately, and (c) match them efficiently with capital providers.
Accelerant’s model—acting as a connective platform between
underwriters and capital—can be attractive in a world where
underwriting discipline and distribution quality matter.

When multiple insiders step in at once, the implied message is often:
“We believe the market is underestimating our earnings power, our
growth trajectory, or the durability of our platform.”

WHAT TO WATCH NEXT (THE “PROOF POINTS”)

*
EXCHANGE GROWTH AND MEMBER TRACTION: Are more underwriters and capital
partners joining, and are existing relationships expanding?

*
LOSS EXPERIENCE AND UNDERWRITING QUALITY: In insurance-adjacent
models, the long-term compounding story depends on disciplined risk
selection.

*
OPERATING LEVERAGE: Platform models can inflect quickly if revenue
scales faster than operating costs.

KEY RISKS

*
CYCLE RISK: Specialty insurance pricing can soften, pressuring
economics.

*
MODEL COMPLEXITY: Investors may discount “platform” stories until
unit economics are consistently visible.

*
EVENT RISK: Cat losses, reserve adjustments, or counterparty issues
can cause sudden re-ratings.

BOTTOM LINE: ARX fits the classic insider-buying profile investors
like to see—cluster participation suggests management believes the
market is mispricing the platform’s medium-term potential.

-------------------------

_Paradigm Press_

ELON TAKING SPACEX PUBLIC! $100 PRE-IPO OPPORTUNITY OPEN!
[[link removed]]

When SpaceX goes public It’s expected to be the biggest IPO in
HISTORY…
 
AS HIGH AS $1.5 TRILLION BY SOME ESTIMATES.
 
That is an eye-watering amount of money…
 
And Wall Street insiders are salivating at the thought of SpaceX’s
IPO.
 
But the best part…
 
YOU CAN GET A PIECE OF THIS SPACEX ACTION
[[link removed]]
before it goes public…in a regular brokerage account.
 
All thanks pre-IPO play almost no one’s talking about…
 
AND IF YOU ACT FAST, YOU CAN GET IN POSITION FOR LESS THAN $100.

CLICK HERE BEFORE IT’S TOO LATE.
[[link removed]]

-------------------------

2) LUMENT FINANCE TRUST, INC. (SYM: LFT)

RECENT PRICE: about $1.39
INSIDER ACTION: 4 insiders bought ~$128K in shares
WHAT THE COMPANY DOES: Lument Finance Trust is a REIT focused on
commercial real estate (CRE) debt investments, including transitional
floating-rate multifamily mortgage loans and other CRE-related
instruments (mezzanine, preferred equity, CMBS, construction loans,
and related debt).

WHY INSIDER BUYING MATTERS HERE

In mortgage REITs and CRE lenders, insider buying often signals
confidence in one (or more) of the following:

*
CREDIT IS HOLDING UP BETTER THAN FEARED (i.e., impairments and
nonaccruals may be manageable).

*
BOOK VALUE IS MORE RESILIENT THAN THE STOCK IMPLIES.

*
THE DIVIDEND OR DISTRIBUTION POLICY IS MORE SUSTAINABLE THAN THE
MARKET IS PRICING.

Because the market tends to punish CRE exposure aggressively during
uncertainty, insider buying can be a meaningful “tell” that
management believes the price is discounting an overly negative
scenario.

WHAT TO WATCH NEXT (THE “PROOF POINTS”)

*
CREDIT METRICS: delinquency trends, nonaccruals, watch lists, and
realized losses.

*
PORTFOLIO COMPOSITION: loan-to-value discipline, property types,
geographic concentration, and sponsor quality.

*
FUNDING STABILITY: how liabilities reprice relative to assets, and
whether liquidity remains ample in a choppy market.

*
DIVIDEND COVERAGE: investors should focus on what actually supports
distributions over time.

KEY RISKS

*
CRE DOWNTURN RISK: A prolonged downturn in multifamily or broader CRE
can pressure collateral values and cash flows.

*
REFINANCING WALL: Transitional loans can be sensitive to tighter
credit availability and higher rates.

*
SMALL-CAP VOLATILITY: At low share prices, sentiment can move faster
than fundamentals.

BOTTOM LINE: LFT is a classic “high skepticism” pocket of the
market. Insider buying here is most useful as a prompt to re-check
credit trends, book value trajectory, and distribution durability.

-------------------------

_Stansberry Research_

WHAT NO ONE'S SAYING ABOUT AMAZON'S 30K LAYOFF
[[link removed]]

First they cut jobs at Meta... now 30,000 at Amazon – its largest
layoff in history.

What's happening inside these Mag 7 companies, particularly as the
stocks continue to soar to all- time highs?

The same former hedge fund manager who predicted the dot com crash,
the housing crisis and the fall of Lehman is now stepping forward to
explain what's really going on... and what you should be doing with
your money.
 LEARN MORE.
[[link removed]]

-------------------------

COMPANY: ELUTIA INC. (SYM: ELUT)

RECENT PRICE: about $0.6905
INSIDER ACTION: 5 insiders bought ~$106K in shares
WHAT THE COMPANY DOES: Elutia is a commercial-stage company developing
and commercializing drug-eluting biologics products for
neurostimulation and breast reconstruction, with segments including
Device Protection, Women’s Health, and Cardiovascular. It markets
products such as EluPro and CanGaroo for cardiac implantable device
protection, as well as tissue repair and reconstruction products.

WHY INSIDER BUYING MATTERS HERE

In small-cap med-tech and biologics, insider buying often reflects
management’s belief that:

*
A commercial rollout is inflecting, or the pipeline is stronger than
the stock price suggests.

*
The company is approaching a catalyst (new data, reimbursement
progress, expanded indications, sales momentum) that could improve the
narrative.

*
The market is pricing in too much dilution risk relative to the
company’s cash runway and operational plan.

Because ELUT trades at a very low absolute share price, it is also the
kind of stock where sentiment can shift sharply on incremental
progress—making insider buying particularly noteworthy as a
“confidence marker.”

WHAT TO WATCH NEXT (THE “PROOF POINTS”)

*
REVENUE TRACTION: sequential growth, mix, and repeat ordering
patterns.

*
GROSS MARGIN PATH: commercial-stage companies often re-rate when
margins stabilize and scale benefits begin to appear.

*
REIMBURSEMENT AND CLINICAL ADOPTION: especially in hospital channels,
where process and protocol matter.

*
CASH RUNWAY AND FINANCING STRATEGY: investors should track burn rate
and any signals around capital needs.

KEY RISKS

*
DILUTION AND FINANCING RISK: small-cap healthcare frequently requires
capital raises.

*
ADOPTION RISK: products can be clinically compelling yet slow to
penetrate due to workflow friction.

*
EXECUTION RISK: sales force productivity and channel strategy are
decisive.

BOTTOM LINE: ELUT is a higher-risk, higher-volatility setup. Insider
buying does not remove the fundamental risks, but it can be a strong
prompt to evaluate whether the market is missing improving commercial
momentum.

-------------------------

_Stock Alert Daily_

ROBOTICS IS ACCELERATING FAST — HERE ARE 3 STOCKS TO WATCH
[[link removed]]

Robotics has quietly transitioned from a “future trend” to a
present-day economic engine.

From precision medical robotics to autonomous industrial systems,
adoption is accelerating across healthcare, defense, and supply chain
operations — and capital markets are responding.

Our analysts assembled a FREE report featuring 3 robotics companies
demonstrating strong execution and early-stage breakout potential:

• Commercial solutions already deployed in high-growth industries
• Improving analyst sentiment and institutional inflows

• Exposure to a robotics market expected to exceed $200B within this
decade

With momentum strengthening across the sector, timing is becoming a
competitive edge.

👉 [ACCESS THE 3 ROBOTICS STOCKS REPORT — FREE]
[[link removed]]

-------------------------

_Are there any other stocks with recent insider buying that you've got
your eye on right now? What other sectors of the market are you
currently interested in? Hit "reply" to this email and let us know
your thoughts!_

Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431

Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the
Markets. For more information about our privacy practices, please
review our Privacy Policy
[[link removed]]
or our Legal Notices.
[[link removed]]

Behind the Markets
[[link removed]]

Unsubscribe
[[link removed]]

invisiblelink
[[link removed]]